Literature DB >> 23635412

Adherence to cholinesterase inhibitors in Alzheimer's disease: a review.

Roseanna Brady1, John Weinman.   

Abstract

BACKGROUND/AIMS: Treatment adherence is a major problem in numerous medical conditions, and is a particular challenge in patients with Alzheimer's disease (AD).
METHODS: This non-systematic review summarises the current literature on factors that affect adherence to cholinesterase inhibitors, the mainstay of AD treatment. Articles listed on PubMed and published during the last 10 years were included.
RESULTS: Intentional factors affecting adherence include patient, caregiver and prescriber beliefs about therapies and the disease itself. Unintentional factors include tolerability, physical limitations of the patient and caregiver burden. Interventions aiming to improve adherence include educational programmes and new drug delivery methods.
CONCLUSION: Due to the high level of caregiver involvement in the care of patients with AD, strategies that address caregiver concerns may improve adherence.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23635412     DOI: 10.1159/000347140

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  10 in total

Review 1.  Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors.

Authors:  Colleen J Maxwell; Kathryn Stock; Dallas Seitz; Nathan Herrmann
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

2.  Trends in the Prescription and Long-Term Utilization of Antidementia Drugs Among Patients with Alzheimer's Disease in Spain: A Cohort Study Using the Registry of Dementias of Girona.

Authors:  Laia Calvó-Perxas; Oriol Turró-Garriga; Joan Vilalta-Franch; Manuela Lozano-Gallego; Rosa de Eugenio; Fabián Márquez; Olga Carmona; Jordi Gich; Anna Manzano; Marta Viñas; Anna Mª Roig; Josep Garre-Olmo
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

Review 3.  Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer's Diseases: Emerging Paradigms and Strategies.

Authors:  Narayanaperumal Pravin; Krzysztof Jozwiak
Journal:  Int J Mol Sci       Date:  2022-05-29       Impact factor: 6.208

4.  An intervention to maximize medication management by caregivers of persons with memory loss: Intervention overview and two-month outcomes.

Authors:  Jennifer H Lingler; Susan M Sereika; Carolyn M Amspaugh; Janet A Arida; Mary E Happ; Martin P Houze; Robert R Kaufman; Melissa L Knox; Lisa K Tamres; Fengyan Tang; Judith A Erlen
Journal:  Geriatr Nurs       Date:  2016-01-21       Impact factor: 2.361

5.  Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities.

Authors:  Douglas Barthold; Geoffrey Joyce; Patricia Ferido; Emmanuel F Drabo; Zachary A Marcum; Shelly L Gray; Julie Zissimopoulos
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

6.  Medication compliance in Singaporean patients with Alzheimer's disease.

Authors:  Zheng Kang Lum; Ma Serrie P Suministrado; N Venketasubramanian; M Kamran Ikram; Christopher Chen
Journal:  Singapore Med J       Date:  2018-06-22       Impact factor: 1.858

7.  A novel open-source drug-delivery system that allows for first-of-kind simulation of nonadherence to pharmacological interventions in animal disease models.

Authors:  Kyle E Thomson; H Steve White
Journal:  J Neurosci Methods       Date:  2014-09-26       Impact factor: 2.390

8.  Exploring the association between interleukin-1β and its interacting proteins in Alzheimer's disease.

Authors:  Lushuang Xie; Yu Lai; Fang Lei; Sujuan Liu; Ran Liu; Tinghua Wang
Journal:  Mol Med Rep       Date:  2015-01-12       Impact factor: 2.952

9.  Gorge Motions of Acetylcholinesterase Revealed by Microsecond Molecular Dynamics Simulations.

Authors:  Shanmei Cheng; Wanling Song; Xiaojing Yuan; Yechun Xu
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

10.  Differences in treatment for Alzheimer's disease between urban and rural areas in China.

Authors:  Bei Li; Dejun Liu; Qiaoqin Wan; Can Sheng; Xiting Wang; Fangda Leng; Qing Peng; Ting Wang; Ailian Du; Feiqi Zhu; Dunzhu Mima; Huali Wang; Hengge Xie; Zhaoxia Wang; Haiqiang Jin; Yongan Sun
Journal:  Front Neurol       Date:  2022-09-29       Impact factor: 4.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.